 Lupron retards proliferation ovarian epithelial tumor cells serum-free medium patients recurrent ovarian epithelial cancer respond treatment GnRH agonists effect suppression pituitary gonadotropin release present vitro study effects human gonadotropin Pergonal LH/FSH Lupron GnRH agonist proliferation ovarian cancer cell line estrogen receptor negative serum-free defined medium Pergonal IU/mL IU/mL cell proliferation stabilization ovarian tumors vivo due decreased serum gonadotropin Lupron micrograms/mL micrograms/mL cell division day culture dose-dependent manner Flow cytometric cell cycle phase DNA analysis Lupron reversible increase portion cells rest phase controls log growth corresponding decrease portion cells DNA synthesis phase long-term culture weeks Lupron cells experimental cultures cell number similar cultures Lupron effect ovarian cancer cell proliferation independent gonadotropin steroid cell cycle regulatory event duration benefit vivo patients total tumor volume time treatment